Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data

Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial data on...
-May 03, 2024 at 06:36 am EDT
- MarketScreener

Related Keywords

Denmark ,Danish ,Kepler Cheuvreux ,David Evans ,Eli Lilly Zepbound ,Elviira Luoma ,Amanda Cooper ,Novo Wegovy ,Novo Nordisk ,Reuters ,Amgen ,Eli Lilly ,Markets ,